The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

Roivant has its own TYK2/JAK1 inhibitor in development in the form of brepocitinib, which the biopharma licensed from Pfizer ...

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...

Researchers at Duke University Medical Center and Wake Forest University School of Medicine have identified ALDH4A1, a ...

Dr. Ashley Piper, a research microbiologist at USAMRIID, is DHA R&D-MRDC's employee of the quarter for the first quarter of ...

Colony forming cell (CFC) assays using primary bone marrow cells can be used to evaluate toxicities of both ADCs and their payloads on blood progenitor cell lineages. CFC assay results indicates ...

They found that in limpets, the fate of shell-forming cells is specified autonomously, rather than through induction by other cell lineages as previously believed. Mollusks exhibit diverse shell ...

1 Zhongshan Clinical College, Dalian University, Dalian, China 2 National and Local Joint Engineering Laboratory for Orthopedic Implant Material Development, Affiliated Zhongshan Hospital of Dalian ...

These assays are analyzed using flow cytometry and live cell imaging with IncuCyte. IncuCyte-based assays quantify the number of viable target cells and can be multiplexed with an apoptotic readout.